Results from the first South African Health Products Regulatory Authority-approved randomised trial evaluating supplementation of standard antibiotic therapy with a commercially available probiotic in South African women with bacterial vaginosis
Anna-Ursula Happel, Ravesh Singh, Nireshni Mitchev, Koleka Mlisana, Heather B. Jaspan, Shaun L. Barnabas, Jo-Ann S. Passmore
doi: https://doi.org/10.1101/2020.05.04.20090282
Anna-Ursula Happel
1Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa
Ravesh Singh
2School of Laboratory Medicine and Medical Sciences, University of Kwa-Zulu Natal, Durban, South Africa
3National Health Laboratory Service, South Africa
Nireshni Mitchev
2School of Laboratory Medicine and Medical Sciences, University of Kwa-Zulu Natal, Durban, South Africa
Koleka Mlisana
2School of Laboratory Medicine and Medical Sciences, University of Kwa-Zulu Natal, Durban, South Africa
3National Health Laboratory Service, South Africa
Heather B. Jaspan
1Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa
4Seattle Children’s Hospital, Seattle, USA
Shaun L. Barnabas
1Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa
5Family Clinic Research Unit, Stellenbosch University, Tygerberg, South Africa
Jo-Ann S. Passmore
1Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa
3National Health Laboratory Service, South Africa
6NRF-DST CAPRISA Centre of Excellence in HIV Prevention, Cape Town, South Africa
Data Availability
The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.
Posted May 08, 2020.
Results from the first South African Health Products Regulatory Authority-approved randomised trial evaluating supplementation of standard antibiotic therapy with a commercially available probiotic in South African women with bacterial vaginosis
Anna-Ursula Happel, Ravesh Singh, Nireshni Mitchev, Koleka Mlisana, Heather B. Jaspan, Shaun L. Barnabas, Jo-Ann S. Passmore
medRxiv 2020.05.04.20090282; doi: https://doi.org/10.1101/2020.05.04.20090282
Results from the first South African Health Products Regulatory Authority-approved randomised trial evaluating supplementation of standard antibiotic therapy with a commercially available probiotic in South African women with bacterial vaginosis
Anna-Ursula Happel, Ravesh Singh, Nireshni Mitchev, Koleka Mlisana, Heather B. Jaspan, Shaun L. Barnabas, Jo-Ann S. Passmore
medRxiv 2020.05.04.20090282; doi: https://doi.org/10.1101/2020.05.04.20090282
Subject Area
Subject Areas
- Addiction Medicine (313)
- Allergy and Immunology (616)
- Anesthesia (158)
- Cardiovascular Medicine (2253)
- Dermatology (199)
- Emergency Medicine (368)
- Epidemiology (11542)
- Forensic Medicine (10)
- Gastroenterology (676)
- Genetic and Genomic Medicine (3539)
- Geriatric Medicine (336)
- Health Economics (611)
- Health Informatics (2283)
- Health Policy (909)
- Hematology (333)
- HIV/AIDS (741)
- Medical Education (357)
- Medical Ethics (100)
- Nephrology (385)
- Neurology (3322)
- Nursing (189)
- Nutrition (504)
- Oncology (1747)
- Ophthalmology (521)
- Orthopedics (208)
- Otolaryngology (283)
- Pain Medicine (221)
- Palliative Medicine (66)
- Pathology (434)
- Pediatrics (997)
- Primary Care Research (398)
- Public and Global Health (5966)
- Radiology and Imaging (1213)
- Respiratory Medicine (806)
- Rheumatology (367)
- Sports Medicine (309)
- Surgery (383)
- Toxicology (50)
- Transplantation (169)
- Urology (142)